Some researchers and drug companies are looking to people with essential fructosuria as inspiration for anti-obesity treatments, Bloomberg reports.

People with this rare genetic condition are unable to metabolize fructose, have an aversion to sweets, and appear to be at a decreased risk of developing obesity, type 2 diabetes, and some liver conditions, Bloomberg adds.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

An artificial intelligence-based analysis suggests a third group of ancient hominins likely interbred with human ancestors, according to Popular Mechanics.

In Science this week: reduction in bee phylogenetic diversity, and more.

The New York Times Magazine looks into paleogenomics and how it is revising what's know about human history, but also possibly ignoring lessons learned by archaeologists.

The Economist reports on Synthorx's efforts to use expanded DNA bases they generated to develop a new cancer drug.